Xconomy Boston

Proteon Therapeutics Inc. Garners $12,000,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a4ec505d-bc5c-41ea-9428-3e30cb470441&Preview=1
Date
5/28/2009
Company Name
Proteon Therapeutics Inc.
Mailing Address
200 West Street Waltham, MA 02451
Company Description
Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
Website
http://www.proteontherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$12,000,000
Transaction Round
Series B
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Bessemer Venture Partners
Venture Investor
Devon Park Bioventures